Basic Information
Basic information for MIR646HG-221-14aa-1
Peptide Name MIR646HG-221-14aa-1
Genome Position chr20:60098955-60098963,60100171-60100203[+]
Species Human
Peptide Sequence MVQKGTSLTKLLLL
Peptide Length 14
Unique No (MIR646HG-202-14aa,MIR646HG-209-14aa,MIR646HG-210-14aa,MIR646HG-222-14aa,MIR646HG-233-14aa,MIR646HG-244-14aa,MIR646HG-246-14aa,MIR646HG-249-14aa,MIR646HG-253-14aa,MIR646HG-254-14aa,MIR646HG-271-14aa)
Grand Average of Hydropathicity 0.8
Relative Molecular Mass 1779.22
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000654422;MIR646HG-221
Transcript Length 1232
Coding Ability 0.3977
DNA Sequence Corresponding to Peptide ATGGTGCAGAAAGGGACCAGCTTGACGAAGCTTCTGCTTTTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :